Tempest Therapeutics Inc (TPST)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,805 | 7,707 | 7,514 | 14,280 | 21,511 |
| TOTAL | $2,446 | $8,269 | $8,104 | $15,103 | $22,433 |
| Non-Current Assets | |||||
| PPE Net | 545 | 605 | 681 | 748 | 817 |
| Other Non-Current Assets | 7,757 | 8,057 | 8,344 | 8,633 | 8,914 |
| TOTAL | $8,302 | $8,662 | $9,025 | $9,381 | $9,731 |
| Total Assets | $10,748 | $16,931 | $17,129 | $24,484 | $32,164 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 585 | 1,038 | 922 | 4,716 | 6,413 |
| Accrued Expenses | 1,487 | 1,084 | 1,456 | 1,322 | 5,703 |
| TOTAL | $3,311 | $3,314 | $3,525 | $7,141 | $13,177 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 6,615 | 6,949 | 7,258 | 7,560 | 7,854 |
| TOTAL | $6,615 | $6,949 | $7,258 | $7,560 | $7,854 |
| Total Liabilities | $9,926 | $10,263 | $10,783 | $14,701 | $21,031 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 14,807 | 14,344 | 4,440 | 4,440 | 3,682 |
| Common Shares | 14 | 5 | 4 | 4 | 4 |
| Retained earnings | -270,072 | -233,368 | -229,347 | -225,836 | -217,966 |
| TOTAL | $822 | $6,668 | $6,346 | $9,783 | $11,133 |
| Total Liabilities And Equity | $10,748 | $16,931 | $17,129 | $24,484 | $32,164 |